Zurn Elkay Water Solutions Reports Third Quarter 2022 Financial Results
Zurn Elkay Water Solutions Corporation (NYSE:ZWS) reported third-quarter 2022 results, showing a significant 82% increase in net sales to $418 million from $230 million year-over-year. The net loss from continuing operations was $(19) million (diluted EPS of $(0.11)), compared to income of $16 million (diluted EPS of $0.13) last year. Adjusted EPS rose to $0.26 from $0.19. EBITDA was $84 million (20.0% of net sales), and net debt leverage stood at 1.6x. Looking ahead, the company expects sales in Q4 between $350 million and $365 million, anticipating challenges in the residential sector.
- Net sales increased 82% year-over-year to $418 million.
- Adjusted EPS rose to $0.26 from $0.19 in the previous year.
- The integration with Elkay is on track, with a projected synergy of $50 million.
- Net loss from continuing operations was $(19) million compared to a net income of $16 million last year.
- Sales guidance for residential market is anticipated to decline by ~20% year-over-year.
Investor call scheduled for
Third Quarter Highlights
-
On
July 1, 2022 completed the combination withElkay Manufacturing Company (“Elkay”), a market leader of commercial drinking water solutions. -
Net sales in the quarter increased
82% to compared with$418 million in last year’s September quarter (+$230 million 16% core sales(1), +67% acquisitions, -1% foreign currency translation). -
Net loss from continuing operations was
(diluted EPS from continuing operations of$(19) million ) compared with net income from continuing operations of$(0.11) (diluted EPS from continuing operations of$16 million ) in the year-ago quarter.$0.13 -
Adjusted EPS(1) was
compared with$0.26 in the year-ago quarter.$0.19 -
Adjusted EBITDA(1) was
($84 million 20.0% of net sales) compared with ($51 million 22.2% of net sales) in last year's third quarter. Corporate costs were compared to$7 million in last year's third quarter.$10 million -
Net debt leverage of 1.6x as of
September 30, 2022 .
Fourth Quarter Outlook
Adams continued, “As we think about our outlook, we believe we have a unique set of competitive advantages that help position us to perform well amidst a difficult macro-environment. Our business is
Notwithstanding our confidence in performing across market environments, we believe customer sentiment and market behavior will be more volatile, particularly heading into a year-end and what appears to be a deteriorating macro-environment. To this end, we've introduced incremental conservatism into our fourth-quarter guidance. In particular, given early signs of residential softness, we are reducing our sales expectations for the residential portion of our business compared to our view 90 days ago and executing on an incremental
For the fourth quarter, we expect sales to be in a range of
Third Quarter 2022 Overview
Net sales were
During the three months ended
Adjusted EBITDA(1), excluding corporate costs of
(1) |
Refer to "Non-GAAP Financial Measures" for a definition of this non-GAAP metric, as well as the accompanying reconciliations to GAAP. |
Non-GAAP Financial Measures
The following non-GAAP financial measures are utilized by management in comparing our operating performance on a consistent basis. We believe that these financial measures are appropriate to enhance an overall understanding of our underlying operating performance trends compared to historical and prospective periods and our peers. Management also believes that these measures are useful to investors in their analysis of our results of operations and provide improved comparability between fiscal periods as well as insight into the compliance with our debt covenants. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to our GAAP results has been provided in the financial tables included in this press release.
Core Sales
Core sales excludes the impact of acquisitions (such as the Elkay and
Adjusted Net Income and Adjusted Earnings Per Share
Adjusted net income and adjusted earnings per share (calculated on a diluted basis) exclude actuarial gains and losses on pension and postretirement benefit obligations, restructuring and other similar charges, gains or losses on divestitures, discontinued operations, gains or losses on extinguishment of debt, the impact of acquisition-related fair value adjustments in connection with purchase accounting, amortization of intangible assets, the adjustment to state inventories at last-in first-out costs, and other non-operational, non-cash or non-recurring losses, net of their income tax impact. The tax rates used to calculate adjusted net income and adjusted earnings per share are based on a transaction specific basis. We believe that adjusted net income and adjusted earnings per share are useful in assessing our financial performance by excluding items that are not indicative of our core operating performance or that may obscure trends useful in evaluating our continuing results of operations. All references to Net Income and EPS within this earnings release refer to net income attributable to
EBITDA
EBITDA represents earnings from continuing operations before interest and other debt related activities, taxes, depreciation and amortization. EBITDA is presented because it is an important supplemental measure of performance and it is frequently used by analysts, investors and other interested parties in the evaluation of companies in our industry. EBITDA is also presented and compared by analysts and investors in evaluating our ability to meet debt service obligations. Other companies in our industry may calculate EBITDA differently. EBITDA is not a measurement of financial performance under GAAP and should not be considered as an alternative to cash flow from operating activities or as a measure of liquidity or an alternative to net income as an indicator of operating performance or any other measures of performance derived in accordance with GAAP. Because EBITDA is calculated before recurring cash charges, including interest expense and taxes, and is not adjusted for capital expenditures or other recurring cash requirements of the business, it should not be considered as a measure of discretionary cash available to invest in the growth of the business.
Adjusted EBITDA
“Adjusted EBITDA” is the term we use to describe EBITDA as defined and adjusted in our credit agreement, which is net income, adjusted for the items summarized in the Reconciliation of GAAP to Non-GAAP Financial Measures table below. Adjusted EBITDA is intended to show our unleveraged, pre-tax operating results and therefore reflects our financial performance based on operational factors, excluding non-operational, non-cash or non-recurring losses or gains. It is also provided to aid investors in understanding our compliance with our debt covenants. Adjusted EBITDA is not a presentation made in accordance with GAAP, and our use of the term Adjusted EBITDA varies from others in our industry. In addition to Adjusted EBITDA we also use the term "Adjusted EBITDA excluding corporate costs" which is used to described our total Adjusted EBITDA at the operating level without being burdened by the EBITDA costs associated with our corporate functions. Adjusted EBITDA should not be considered as an alternative to net income, income from operations or any other performance measures derived in accordance with GAAP. Adjusted EBITDA has important limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for, analysis of our results as reported under GAAP. For example, Adjusted EBITDA does not reflect: (a) our capital expenditures, future requirements for capital expenditures or contractual commitments; (b) changes in, or cash requirements for, our working capital needs; (c) interest expenses, or the cash requirements necessary to service interest or principal payments, on our debt; (d) tax payments that represent a reduction in cash available to us; (e) any cash requirements for the assets being depreciated and amortized that may have to be replaced in the future; or (f) the impact of earnings or charges resulting from matters that we and the lenders under our credit agreement may not consider indicative of our ongoing operations. In particular, our definition of Adjusted EBITDA adds back certain non-cash, non-operating or non-recurring charges that are deducted in calculating net income, even though these are expenses that may recur, vary greatly and are difficult to predict and can represent the effect of long-term strategies as opposed to short-term results.
In addition, certain of these excluded expenses can represent the reduction of cash that could be used for other corporate purposes. Further, although not included in the calculation of Adjusted EBITDA below, the measure may at times allow us to add estimated cost savings and operating synergies related to operational changes ranging from acquisitions to dispositions to restructurings and/or exclude one-time transition expenditures that we anticipate we will need to incur to realize cost savings before such savings have occurred. Further, management and various investors use the ratio of total debt less cash to Adjusted EBITDA (which includes a full pro-forma last-twelve-month impact of acquisitions), which we refer to as "net debt leverage", as a measure of our financial strength and ability to incur incremental indebtedness when making key investment decisions and evaluating us against peers. Lastly, management and various investors use the ratio of the change in Adjusted EBITDA divided by the change in net sales (referred to as “incremental margin” in the case of an increase in net sales or “decremental margin” in the case of a decrease in net sales) as an additional measure of our financial performance and this ratio is utilized by management when making key investment decisions and evaluating us against peers.
Free Cash Flow
We define Free Cash Flow as cash flow from operations less capital expenditures, and we use this metric in analyzing our ability to service and repay our debt and to forecast future periods. However, this measure does not represent funds available for investment or other discretionary uses since it does not deduct cash used to service our debt. We define Free Cash Flow Conversion as Free Cash Flow divided by net income.
Return on
ROIC is used because we believe it is an important supplemental measure of financial performance and it is also currently a performance measure under our long-term incentive plan. ROIC is frequently used by analysts, investors and other interested parties in the evaluation of companies in our industry. ROIC is also used by investors and analysts to evaluate management’s deployment of capital to create shareholder value. We define ROIC as tax-effected net operating income for the last 12 months divided by average total invested capital over a rolling four-quarter period. Total invested capital is defined as stockholders' equity plus debt, less cash and cash equivalents. Other companies may not define or calculate ROIC in the same way.
About
Headquartered in
Conference Call Details
Domestic toll-free: 888-510-2359
International toll: 646-960-0215
Access Code: 7660247
A live webcast of the call will also be available on our investor relations website. Please go to the website (investors.zurn-elkay.com) at least 15 minutes prior to the start of the call to register, download and install any necessary audio software.
If you are unable to participate during the live teleconference, a replay of the conference call will be available from
Cautionary Statement on Forward-Looking Statements
Information in this release may involve outlook, expectations, beliefs, plans, intentions, strategies or other statements regarding the future, which are forward-looking statements. These forward-looking statements involve risks and uncertainties. All forward-looking statements included in this release are based on information available to
Condensed Consolidated Statements of Operations (in Millions, except share and per share amounts) (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
|
|
|
|
|
|
||||||||
Net sales |
$ |
417.7 |
|
|
$ |
229.7 |
|
|
$ |
941.5 |
|
|
$ |
678.6 |
|
Cost of sales |
|
277.3 |
|
|
|
133.9 |
|
|
|
585.4 |
|
|
|
390.6 |
|
Gross profit |
|
140.4 |
|
|
|
95.8 |
|
|
|
356.1 |
|
|
|
288.0 |
|
Selling, general and administrative expenses |
|
124.3 |
|
|
|
56.8 |
|
|
|
236.6 |
|
|
|
174.9 |
|
Restructuring and other similar charges |
|
11.7 |
|
|
|
0.7 |
|
|
|
13.1 |
|
|
|
1.6 |
|
Amortization of intangible assets |
|
14.5 |
|
|
|
5.8 |
|
|
|
19.1 |
|
|
|
17.7 |
|
(Loss) income from operations |
|
(10.1 |
) |
|
|
32.5 |
|
|
|
87.3 |
|
|
|
93.8 |
|
Non-operating expense: |
|
|
|
|
|
|
|
||||||||
Interest expense, net |
|
(8.0 |
) |
|
|
(9.9 |
) |
|
|
(18.0 |
) |
|
|
(29.6 |
) |
Other income (expense), net |
|
0.6 |
|
|
|
(0.8 |
) |
|
|
0.3 |
|
|
|
(0.9 |
) |
(Loss) income before income taxes |
|
(17.5 |
) |
|
|
21.8 |
|
|
|
69.6 |
|
|
|
63.3 |
|
Provision for income taxes |
|
(1.6 |
) |
|
|
(5.7 |
) |
|
|
(22.9 |
) |
|
|
(16.6 |
) |
Net (loss) income from continuing operations |
|
(19.1 |
) |
|
|
16.1 |
|
|
|
46.7 |
|
|
|
46.7 |
|
Income from discontinued operations, net of tax |
|
— |
|
|
|
48.0 |
|
|
|
0.8 |
|
|
|
140.6 |
|
Net (loss) income attributable to Zurn Elkay common stockholders |
$ |
(19.1 |
) |
|
$ |
64.1 |
|
|
$ |
47.5 |
|
|
$ |
187.3 |
|
|
|
|
|
|
|
|
|
||||||||
Basic net (loss) income per share: |
|
|
|
|
|
|
|
||||||||
Continuing operations |
$ |
(0.11 |
) |
|
$ |
0.13 |
|
|
$ |
0.33 |
|
|
$ |
0.39 |
|
Discontinued operations |
$ |
— |
|
|
$ |
0.40 |
|
|
$ |
0.01 |
|
|
$ |
1.17 |
|
Net (loss) income |
$ |
(0.11 |
) |
|
$ |
0.53 |
|
|
$ |
0.33 |
|
|
$ |
1.55 |
|
Diluted net (loss) income per share: |
|
|
|
|
|
|
|
||||||||
Continuing operations |
$ |
(0.11 |
) |
|
$ |
0.13 |
|
|
$ |
0.32 |
|
|
$ |
0.38 |
|
Discontinued operations |
$ |
— |
|
|
$ |
0.38 |
|
|
$ |
0.01 |
|
|
$ |
1.13 |
|
Net (loss) income |
$ |
(0.11 |
) |
|
$ |
0.51 |
|
|
$ |
0.33 |
|
|
$ |
1.50 |
|
Weighted-average number of shares outstanding (in thousands): |
|
|
|
|
|
|
|
||||||||
Basic |
|
174,867 |
|
|
|
121,385 |
|
|
|
142,699 |
|
|
|
120,558 |
|
Effect of dilutive equity awards |
|
— |
|
|
|
3,703 |
|
|
|
2,004 |
|
|
|
3,968 |
|
Diluted |
|
174,867 |
|
|
|
125,088 |
|
|
|
144,703 |
|
|
|
124,526 |
|
Reconciliation of GAAP to Non-GAAP Financial Measures
Three Months Ended (in Millions) (Unaudited) |
|||||||||||||||||||||
|
|
Three Months Ended |
|||||||||||||||||||
|
|
Reported
|
|
|
|
Adjustments |
|
|
|
Non-GAAP
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
$ |
417.7 |
|
|
|
|
$ |
— |
|
|
|
|
$ |
417.7 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
EBITDA |
|
|
11.5 |
|
|
|
|
|
72.2 |
|
(a) |
|
|
|
83.7 |
|
|
|
|||
Depreciation and amortization |
|
|
(21.6 |
) |
|
|
|
|
— |
|
|
|
|
|
(21.6 |
) |
|
|
|||
(Loss) income from operations |
|
|
(10.1 |
) |
|
|
|
|
72.2 |
|
(b) |
|
|
|
62.1 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
(Loss) income before income taxes |
|
|
(17.5 |
) |
|
|
|
|
78.3 |
|
(c) |
|
|
|
60.8 |
|
|
|
|||
Provision for income taxes and indicated rate |
|
|
(1.6 |
) |
|
(9.1 |
) % |
|
|
(14.0 |
) |
|
17.9 |
% |
|
|
(15.6 |
) |
|
25.7 |
% |
Net (loss) income from continuing operations |
|
|
(19.1 |
) |
|
|
|
|
64.3 |
|
|
|
|
|
45.2 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Income from discontinued operations, net of tax |
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
— |
|
|
|
|||
Net (loss) income attributable to Zurn Elkay common stockholders |
|
$ |
(19.1 |
) |
|
|
|
$ |
64.3 |
|
|
|
|
$ |
45.2 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
EBITDA
|
|
|
|
Income from
|
|
|
|
Income before
|
|
|
|||||||||
Restructuring and other similar charges |
|
$ |
11.7 |
|
|
|
|
$ |
11.7 |
|
|
|
|
$ |
11.7 |
|
|
|
|||
Acquisition-related fair value adjustment |
|
|
14.6 |
|
|
|
|
|
14.6 |
|
|
|
|
|
14.6 |
|
|
|
|||
Merger costs |
|
|
33.7 |
|
|
|
|
|
33.7 |
|
|
|
|
|
33.7 |
|
|
|
|||
Last-in-first-out inventory adjustments |
|
|
4.4 |
|
|
|
|
|
4.4 |
|
|
|
|
|
4.4 |
|
|
|
|||
Stock-based compensation expense |
|
|
7.8 |
|
|
|
|
|
7.8 |
|
|
|
|
|
— |
|
|
|
|||
Amortization of intangible assets |
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
14.5 |
|
|
|
|||
Other income, net (1) |
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
(0.6 |
) |
|
|
|||
Total Adjustments |
|
$ |
72.2 |
|
|
|
|
$ |
72.2 |
|
|
|
|
$ |
78.3 |
|
|
|
____________________
(1) |
Other income, net for the periods indicated, consists primarily of gains and losses from foreign currency transactions and the non-service cost components of net periodic benefit credits associated with our defined benefit plans. |
Reconciliation of GAAP to Non-GAAP Financial Measures
Nine Months Ended (in Millions) (Unaudited) |
|||||||||||||||||||||
|
|
Nine Months Ended |
|||||||||||||||||||
|
|
Reported
|
|
|
|
Adjustments |
|
|
|
Non-GAAP
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
$ |
941.5 |
|
|
|
|
$ |
— |
|
|
|
|
$ |
941.5 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
EBITDA |
|
|
118.2 |
|
|
|
|
|
81.8 |
|
(a) |
|
|
|
200.0 |
|
|
|
|||
Depreciation and amortization |
|
|
(30.9 |
) |
|
|
|
|
— |
|
|
|
|
|
(30.9 |
) |
|
|
|||
Income from operations |
|
|
87.3 |
|
|
|
|
|
81.8 |
|
(b) |
|
|
|
169.1 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Income before income taxes |
|
|
69.6 |
|
|
|
|
|
85.1 |
|
(c) |
|
|
|
154.7 |
|
|
|
|||
Provision for income taxes and indicated rate |
|
|
(22.9 |
) |
|
32.9 |
% |
|
|
(15.5 |
) |
|
18.2 |
% |
|
|
(38.4 |
) |
|
24.8 |
% |
Net income from continuing operations |
|
|
46.7 |
|
|
|
|
|
69.6 |
|
|
|
|
|
116.3 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Income from discontinued operations, net of tax |
|
|
0.8 |
|
|
|
|
|
(0.8 |
) |
|
|
|
|
— |
|
|
|
|||
Net income attributable to Zurn Elkay common stockholders |
|
$ |
47.5 |
|
|
|
|
$ |
68.8 |
|
|
|
|
$ |
116.3 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
EBITDA
|
|
|
|
Income from
|
|
|
|
Income before
|
|
|
|||||||||
Restructuring and other similar charges |
|
$ |
13.1 |
|
|
|
|
$ |
13.1 |
|
|
|
|
$ |
13.1 |
|
|
|
|||
Acquisition-related fair value adjustment |
|
|
15.2 |
|
|
|
|
|
15.2 |
|
|
|
|
|
15.2 |
|
|
|
|||
Other, net (1) |
|
|
0.3 |
|
|
|
|
|
0.3 |
|
|
|
|
|
0.3 |
|
|
|
|||
Merger costs |
|
|
33.7 |
|
|
|
|
|
33.7 |
|
|
|
|
|
33.7 |
|
|
|
|||
Last-in-first-out inventory adjustments |
|
|
4.0 |
|
|
|
|
|
4.0 |
|
|
|
|
|
4.0 |
|
|
|
|||
Stock-based compensation expense |
|
|
15.5 |
|
|
|
|
|
15.5 |
|
|
|
|
|
— |
|
|
|
|||
Amortization of intangible assets |
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
19.1 |
|
|
|
|||
Other income, net (2) |
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
(0.3 |
) |
|
|
|||
Total Adjustments |
|
$ |
81.8 |
|
|
|
|
$ |
81.8 |
|
|
|
|
$ |
85.1 |
|
|
|
____________________
(1) |
Other, net includes the gains and losses from sale of long-lived assets. |
(2) |
Other income, net for the periods indicated, consists primarily of gains and losses from foreign currency transactions and the non-service cost components of net periodic benefit credits associated with our defined benefit plans. |
Reconciliation of GAAP to Non-GAAP Financial Measures
Three Months Ended (in Millions) (Unaudited) |
|||||||||||||||||||||
|
|
Three Months Ended |
|||||||||||||||||||
|
|
Reported
|
|
|
|
Adjustments |
|
|
|
Non-GAAP
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
$ |
229.7 |
|
|
|
|
$ |
— |
|
|
|
|
$ |
229.7 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
EBITDA |
|
|
40.6 |
|
|
|
|
|
10.3 |
|
(a) |
|
|
|
50.9 |
|
|
|
|||
Depreciation and amortization |
|
|
(8.1 |
) |
|
|
|
|
— |
|
|
|
|
|
(8.1 |
) |
|
|
|||
Income from operations |
|
|
32.5 |
|
|
|
|
|
10.3 |
|
(b) |
|
|
|
42.8 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Income before income taxes |
|
|
21.8 |
|
|
|
|
|
9.9 |
|
(c) |
|
|
|
31.7 |
|
|
|
|||
Provision for income taxes and indicated rate |
|
|
(5.7 |
) |
|
26.1 |
% |
|
|
(2.0 |
) |
|
20.2 |
% |
|
|
(7.7 |
) |
|
24.3 |
% |
Net income from continuing operations |
|
|
16.1 |
|
|
|
|
|
7.9 |
|
|
|
|
|
24.0 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Income from discontinued operations, net of tax |
|
|
48.0 |
|
|
|
|
|
(48.0 |
) |
|
|
|
|
— |
|
|
|
|||
Net income attributable to Zurn Elkay common stockholders |
|
$ |
64.1 |
|
|
|
|
$ |
(40.1 |
) |
|
|
|
$ |
24.0 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
EBITDA
|
|
|
|
Income from
|
|
|
|
Income before
|
|
|
|||||||||
Restructuring and other similar charges |
|
$ |
0.7 |
|
|
|
|
$ |
0.7 |
|
|
|
|
$ |
0.7 |
|
|
|
|||
Last-in-first-out inventory adjustments |
|
|
2.6 |
|
|
|
|
|
2.6 |
|
|
|
|
|
2.6 |
|
|
|
|||
Stock-based compensation expense |
|
|
7.0 |
|
|
|
|
|
7.0 |
|
|
|
|
|
— |
|
|
|
|||
Amortization of intangible assets |
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
5.8 |
|
|
|
|||
Other expense, net (1) |
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
0.8 |
|
|
|
|||
Total Adjustments |
|
$ |
10.3 |
|
|
|
|
$ |
10.3 |
|
|
|
|
$ |
9.9 |
|
|
|
____________________
(1) |
Other expense, net for the periods indicated, consists primarily of gains and losses from foreign currency transactions and the non-service cost components of net periodic benefit credits associated with our defined benefit plans. |
Reconciliation of GAAP to Non-GAAP Financial Measures
Nine Months Ended (in Millions) (Unaudited) |
|||||||||||||||||||||
|
|
Nine Months Ended |
|||||||||||||||||||
|
|
Reported
|
|
|
|
Adjustments |
|
|
|
Non-GAAP
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
$ |
678.6 |
|
|
|
|
$ |
— |
|
|
|
|
$ |
678.6 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
EBITDA |
|
|
118.4 |
|
|
|
|
|
32.3 |
|
(a) |
|
|
|
150.7 |
|
|
|
|||
Depreciation and amortization |
|
|
(24.6 |
) |
|
|
|
|
— |
|
|
|
|
|
(24.6 |
) |
|
|
|||
Income from operations |
|
|
93.8 |
|
|
|
|
|
32.3 |
|
(b) |
|
|
|
126.1 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Income before income taxes |
|
|
63.3 |
|
|
|
|
|
27.7 |
|
(c) |
|
|
|
91.0 |
|
|
|
|||
Provision for income taxes and indicated rate |
|
|
(16.6 |
) |
|
26.2 |
% |
|
|
(6.4 |
) |
|
23.1 |
% |
|
|
(23.0 |
) |
|
25.3 |
% |
Net income from continuing operations |
|
|
46.7 |
|
|
|
|
|
21.3 |
|
|
|
|
|
68.0 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Income from discontinued operations, net of tax |
|
|
140.6 |
|
|
|
|
|
(140.6 |
) |
|
|
|
|
— |
|
|
|
|||
Net income attributable to Zurn Elkay common stockholders |
|
$ |
187.3 |
|
|
|
|
$ |
(119.3 |
) |
|
|
|
$ |
68.0 |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
EBITDA
|
|
|
|
Income from
|
|
|
|
Income before
|
|
|
|||||||||
Restructuring and other similar charges |
|
$ |
1.6 |
|
|
|
|
$ |
1.6 |
|
|
|
|
$ |
1.6 |
|
|
|
|||
Acquisition-related fair value adjustment |
|
|
0.6 |
|
|
|
|
|
0.6 |
|
|
|
|
|
0.6 |
|
|
|
|||
Last-in-first-out inventory adjustments |
|
|
6.9 |
|
|
|
|
|
6.9 |
|
|
|
|
|
6.9 |
|
|
|
|||
Stock-based compensation expense |
|
|
23.2 |
|
|
|
|
|
23.2 |
|
|
|
|
|
— |
|
|
|
|||
Amortization of intangible assets |
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
17.7 |
|
|
|
|||
Other expense, net (1) |
|
|
— |
|
|
|
|
|
— |
|
|
|
|
|
0.9 |
|
|
|
|||
Total Adjustments |
|
$ |
32.3 |
|
|
|
|
$ |
32.3 |
|
|
|
|
$ |
27.7 |
|
|
|
____________________
(1) |
Other expense, net for the periods indicated, consists primarily of gains and losses from foreign currency transactions and the non-service cost components of net periodic benefit credits associated with our defined benefit plans. |
Reconciliation of GAAP to Non-GAAP Financial Measures
Three and Nine Months Ended (in Millions, except share and per share amounts) (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
Adjusted EBITDA |
|
|
|
|
|
|
|
||||||||
Net (loss) income attributable to Zurn Elkay common stockholders |
$ |
(19.1 |
) |
|
$ |
64.1 |
|
|
$ |
47.5 |
|
|
$ |
187.3 |
|
Income from discontinued operations, net of tax (1) |
|
— |
|
|
|
(48.0 |
) |
|
|
(0.8 |
) |
|
|
(140.6 |
) |
Provision for income taxes |
|
1.6 |
|
|
|
5.7 |
|
|
|
22.9 |
|
|
|
16.6 |
|
Other (income) expense, net (2) |
|
(0.6 |
) |
|
|
0.8 |
|
|
|
(0.3 |
) |
|
|
0.9 |
|
Interest expense |
|
8.0 |
|
|
|
9.9 |
|
|
|
18.0 |
|
|
|
29.6 |
|
(Loss) income from operations |
$ |
(10.1 |
) |
|
$ |
32.5 |
|
|
$ |
87.3 |
|
|
$ |
93.8 |
|
|
|
|
|
|
|
|
|
||||||||
Adjustments |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
$ |
21.6 |
|
|
$ |
8.1 |
|
|
$ |
30.9 |
|
|
$ |
24.6 |
|
Restructuring and other similar charges |
|
11.7 |
|
|
|
0.7 |
|
|
|
13.1 |
|
|
|
1.6 |
|
Stock-based compensation expense |
|
7.8 |
|
|
|
7.0 |
|
|
|
15.5 |
|
|
|
23.2 |
|
Merger costs |
|
33.7 |
|
|
|
— |
|
|
|
33.7 |
|
|
|
— |
|
Last-in first-out inventory adjustment |
|
4.4 |
|
|
|
2.6 |
|
|
|
4.0 |
|
|
|
6.9 |
|
Acquisition-related fair value adjustment |
|
14.6 |
|
|
|
— |
|
|
|
15.2 |
|
|
|
0.6 |
|
Other, net (3) |
|
— |
|
|
|
— |
|
|
|
0.3 |
|
|
|
— |
|
Subtotal of adjustments |
|
93.8 |
|
|
|
18.4 |
|
|
|
112.7 |
|
|
|
56.9 |
|
Adjusted EBITDA |
$ |
83.7 |
|
|
$ |
50.9 |
|
|
$ |
200.0 |
|
|
$ |
150.7 |
|
Corporate costs |
$ |
(6.8 |
) |
|
$ |
(10.0 |
) |
|
$ |
(20.5 |
) |
|
$ |
(28.8 |
) |
Adjusted EBITDA before corporate costs |
$ |
90.5 |
|
|
$ |
60.9 |
|
|
$ |
220.5 |
|
|
$ |
179.5 |
|
____________________
(1) |
Income from discontinued operations, net of tax is not included in Adjusted EBITDA in accordance with the terms of our credit agreement. |
(2) |
Other expense, net for the periods indicated, consists primarily of gains and losses from foreign currency transactions and the non-service cost components of net periodic benefit credits associated with our defined benefit plans. |
(3) |
Other, net includes the gains and losses from sale of long-lived assets. |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
Adjusted Net Income and Earnings Per Share |
|
|
|
|
|
|
|
||||||||
Net (loss) income attributable to Zurn Elkay common stockholders |
$ |
(19.1 |
) |
|
$ |
64.1 |
|
|
$ |
47.5 |
|
|
$ |
187.3 |
|
Income from discontinued operations, net of tax |
|
— |
|
|
|
(48.0 |
) |
|
|
(0.8 |
) |
|
|
(140.6 |
) |
Amortization of intangible assets |
|
14.5 |
|
|
|
5.8 |
|
|
|
19.1 |
|
|
|
17.7 |
|
Restructuring and other similar charges |
|
11.7 |
|
|
|
0.7 |
|
|
|
13.1 |
|
|
|
1.6 |
|
Acquisition-related fair value adjustment |
|
14.6 |
|
|
|
— |
|
|
|
15.2 |
|
|
|
0.6 |
|
Merger costs |
|
33.7 |
|
|
|
— |
|
|
|
33.7 |
|
|
|
— |
|
Last-in first-out inventory adjustment |
|
4.4 |
|
|
|
2.6 |
|
|
|
4.0 |
|
|
|
6.9 |
|
Other (income) expense, net (1) |
|
(0.6 |
) |
|
|
0.8 |
|
|
|
(0.3 |
) |
|
|
0.9 |
|
Other, net (2) |
|
— |
|
|
|
— |
|
|
|
0.3 |
|
|
|
— |
|
Tax effect on above items |
|
(14.0 |
) |
|
|
(2.0 |
) |
|
|
(15.5 |
) |
|
|
(6.4 |
) |
Adjusted net income |
$ |
45.2 |
|
|
$ |
24.0 |
|
|
$ |
116.3 |
|
|
$ |
68.0 |
|
|
|
|
|
|
|
|
|
||||||||
GAAP diluted net (loss) income per share from continuing operations |
$ |
(0.11 |
) |
|
$ |
0.13 |
|
|
$ |
0.32 |
|
|
$ |
0.38 |
|
Adjusted earnings per share - diluted |
$ |
0.26 |
|
|
$ |
0.19 |
|
|
$ |
0.80 |
|
|
$ |
0.55 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average number of shares outstanding (in thousands) |
|
|
|
|
|
|
|
||||||||
GAAP basic weighted-average shares |
|
174,867 |
|
|
|
121,385 |
|
|
|
142,699 |
|
|
|
120,558 |
|
Effect of dilutive equity securities |
|
2,035 |
|
|
|
3,703 |
|
|
|
2,004 |
|
|
|
3,968 |
|
Adjusted diluted weighted-average shares |
|
174,867 |
|
|
|
125,088 |
|
|
|
144,703 |
|
|
|
124,526 |
|
____________________
(1) |
Other (income) expense, net for the periods indicated, consists primarily of gains and losses from foreign currency transactions and the non-service cost components of net periodic benefit credits associated with our defined benefit plans. |
(2) |
Other, net includes the gains and losses from the sale of long-lived assets. |
|
|
Three Months Ended(1) |
|
Nine Months Ended(1) |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
Cash provided by operating activities |
|
$ |
24.6 |
|
|
$ |
100.8 |
|
|
$ |
12.6 |
|
|
$ |
245.8 |
|
Expenditures for property, plant and equipment |
|
|
(2.3 |
) |
|
|
(7.6 |
) |
|
|
(4.3 |
) |
|
|
(21.6 |
) |
Free cash flow |
|
$ |
22.3 |
|
|
$ |
93.2 |
|
|
$ |
8.3 |
|
|
$ |
224.2 |
|
(1) |
The condensed consolidated statements of cash flows for the periods ended |
Condensed Consolidated Statements of Comprehensive Income (in Millions) (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
|
|
|
|
|
|
||||||||
Net (loss) income |
$ |
(19.1 |
) |
|
$ |
64.1 |
|
|
$ |
47.5 |
|
|
$ |
187.3 |
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustments |
|
(4.1 |
) |
|
|
(10.3 |
) |
|
|
(4.1 |
) |
|
|
(6.6 |
) |
Change in pension and postretirement defined benefit plans, net of tax |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(0.2 |
) |
Other comprehensive loss, net of tax |
|
(4.1 |
) |
|
|
(10.3 |
) |
|
|
(4.1 |
) |
|
|
(6.8 |
) |
Total comprehensive (loss) income |
$ |
(23.2 |
) |
|
$ |
53.8 |
|
|
$ |
43.4 |
|
|
$ |
180.5 |
|
Condensed Consolidated Balance Sheets (in Millions, except share amounts) |
||||||||
|
|
(Unaudited) |
|
|
||||
|
|
|
|
|
||||
Assets |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
71.9 |
|
|
$ |
96.6 |
|
Receivables, net |
|
|
269.1 |
|
|
|
144.1 |
|
Inventories, net |
|
|
400.2 |
|
|
|
184.5 |
|
Income taxes receivable |
|
|
24.5 |
|
|
|
33.1 |
|
Other current assets |
|
|
34.8 |
|
|
|
16.5 |
|
Total current assets |
|
|
800.5 |
|
|
|
474.8 |
|
Property, plant and equipment, net |
|
|
203.0 |
|
|
|
64.4 |
|
Intangible assets, net |
|
|
1,019.1 |
|
|
|
179.1 |
|
|
|
|
754.8 |
|
|
|
254.1 |
|
Insurance for asbestos claims |
|
|
66.0 |
|
|
|
66.0 |
|
Other assets |
|
|
83.6 |
|
|
|
39.3 |
|
Total assets |
|
$ |
2,927.0 |
|
|
$ |
1,077.7 |
|
Liabilities and stockholders' equity |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Current maturities of debt |
|
$ |
5.7 |
|
|
$ |
5.6 |
|
Trade payables |
|
|
144.5 |
|
|
|
105.1 |
|
Compensation and benefits |
|
|
27.4 |
|
|
|
22.0 |
|
Current portion of pension and postretirement benefit obligations |
|
|
1.3 |
|
|
|
1.3 |
|
Other current liabilities |
|
|
149.8 |
|
|
|
106.4 |
|
Total current liabilities |
|
|
328.7 |
|
|
|
240.4 |
|
|
|
|
|
|
||||
Long-term debt |
|
|
531.3 |
|
|
|
533.9 |
|
Pension and postretirement benefit obligations |
|
|
58.7 |
|
|
|
57.3 |
|
Deferred income taxes |
|
|
229.8 |
|
|
|
3.1 |
|
Operating lease liability |
|
|
51.2 |
|
|
|
8.9 |
|
Reserve for asbestos claims |
|
|
66.0 |
|
|
|
66.0 |
|
Other liabilities |
|
|
42.7 |
|
|
|
41.7 |
|
Total liabilities |
|
|
1,308.4 |
|
|
|
951.3 |
|
|
|
|
|
|
||||
Stockholders' equity: |
|
|
|
|
||||
Common stock, |
|
|
1.8 |
|
|
|
1.3 |
|
Additional paid-in capital |
|
|
2,850.2 |
|
|
|
1,436.9 |
|
Retained deficit |
|
|
(1,154.4 |
) |
|
|
(1,236.9 |
) |
Accumulated other comprehensive loss |
|
|
(79.0 |
) |
|
|
(74.9 |
) |
Total stockholders' equity |
|
|
1,618.6 |
|
|
|
126.4 |
|
Total liabilities and stockholders' equity |
|
$ |
2,927.0 |
|
|
$ |
1,077.7 |
|
Condensed Consolidated Statements of Cash Flows (in Millions) (Unaudited) |
||||||||
|
|
Nine Months Ended |
||||||
|
|
|
|
|
||||
Operating activities |
|
|
|
|
||||
Net income |
|
$ |
47.5 |
|
|
$ |
187.3 |
|
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
|
||||
Depreciation |
|
|
11.8 |
|
|
|
41.8 |
|
Amortization of intangible assets |
|
|
19.1 |
|
|
|
27.6 |
|
Loss (gain) on dispositions of long-lived assets |
|
|
0.3 |
|
|
|
(10.1 |
) |
Deferred income taxes |
|
|
4.1 |
|
|
|
(6.6 |
) |
Other non-cash expenses |
|
|
5.3 |
|
|
|
1.7 |
|
Stock-based compensation expense |
|
|
15.5 |
|
|
|
38.3 |
|
Changes in operating assets and liabilities: |
|
|
|
|
||||
Receivables |
|
|
(34.4 |
) |
|
|
(67.5 |
) |
Inventories |
|
|
(50.9 |
) |
|
|
(58.7 |
) |
Other assets |
|
|
34.8 |
|
|
|
(7.1 |
) |
Accounts payable |
|
|
9.7 |
|
|
|
82.4 |
|
Accruals and other |
|
|
(50.2 |
) |
|
|
16.7 |
|
Cash provided by operating activities |
|
|
12.6 |
|
|
|
245.8 |
|
|
|
|
|
|
||||
Investing activities |
|
|
|
|
||||
Expenditures for property, plant and equipment |
|
|
(4.3 |
) |
|
|
(21.6 |
) |
Acquisitions, net of cash acquired |
|
|
(44.8 |
) |
|
|
(3.4 |
) |
Proceeds from dispositions of long-lived assets |
|
|
1.3 |
|
|
|
14.3 |
|
Proceeds associated with divestiture of discontinued operations |
|
|
35.0 |
|
|
|
4.2 |
|
Cash used for investing activities |
|
|
(12.8 |
) |
|
|
(6.5 |
) |
|
|
|
|
|
||||
Financing activities |
|
|
|
|
||||
Proceeds from borrowings of debt |
|
|
85.0 |
|
|
|
— |
|
Repayments of debt |
|
|
(89.4 |
) |
|
|
(1.7 |
) |
Proceeds from exercise of stock options |
|
|
1.9 |
|
|
|
23.5 |
|
Taxes withheld and paid on employees' share-based payment awards |
|
|
(0.5 |
) |
|
|
(1.4 |
) |
Repurchase of common stock |
|
|
— |
|
|
|
(0.9 |
) |
Payment of common stock dividends |
|
|
(20.1 |
) |
|
|
(32.6 |
) |
Cash used for financing activities |
|
|
(23.1 |
) |
|
|
(13.1 |
) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
(1.4 |
) |
|
|
(4.2 |
) |
(Decrease) increase in cash, cash equivalents and restricted cash |
|
|
(24.7 |
) |
|
|
222.0 |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
96.6 |
|
|
|
255.6 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
71.9 |
|
|
$ |
477.6 |
|
(1) |
The condensed consolidated statements of cash flows for the period ended |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221025006034/en/
Vice President - Investor Relations
414.223.7770
Source:
FAQ
What are Zurn Elkay's Q3 2022 financial results?
What is the sales outlook for Zurn Elkay in Q4 2022?
How did Zurn Elkay's adjusted EPS perform in Q3 2022?